跳至主要内容
临床试验/JPRN-UMIN000000718
JPRN-UMIN000000718已完成未知

Phase II study of using Carbamazepine for neurosensory toxicity related FOLFOX regimens in patients with advanced/recurrent colorectal cancer (OGSG 0603) - OGSG 0603

OGSG0 个研究点目标入组 35 人开始时间: 2007年5月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Patients who received transfusion, blood components or GCSF within seven days Before registration (2) with brain metastasis (3) with much cavity fluid to be removed (4) with active double cancer (5) allergy against medicines (6) uncontrolled Hypertension (7) receiving digitalis (8) uncontrolled DM (9) active infectious disease (10) watery diarrhea (11) disorder on EKG (12) severe respiratory diseases (interstitial pneumonitis, pulmonary fibrosis, Severe pulmonary emphysema) (13) psychiatric disorder (14) fresh bleeding on the digestive tract (15) sensory nerve disorder (16) pregnant and/or nursing women (17) driving a complicated mechanism or vehicle (18) Doctors' stop not to be registered

研究者

发起方
OGSG

相似试验